Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicentre, double-blind, double-dummy, randomised trial on the contraceptive efficacy, tolerability and safety of LPRI-424 (dienogest 2 mg / ethinyl estradiol 0.02 mg) during nine cycles in comparison with drospirenone 3 mg / ethinyl estradiol 0.02 mg

Next Previous
Search
Trial Profile

A multicentre, double-blind, double-dummy, randomised trial on the contraceptive efficacy, tolerability and safety of LPRI-424 (dienogest 2 mg / ethinyl estradiol 0.02 mg) during nine cycles in comparison with drospirenone 3 mg / ethinyl estradiol 0.02 mg

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 09 Feb 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ethinylestradiol/dienogest (Primary) ; Drospirenone/ethinylestradiol
  • Indications Pregnancy
  • Focus Registrational; Therapeutic Use
  • Sponsors Chemo Research, S.L.

    • Most Recent Events

    • 09 Feb 2024 This trial has been completed in Portugal (End Date: 22 Mar 2022), according to European Clinical Trials Database record.
    • 19 Jun 2022 This trial has been completed in Slovakia (Global end date: 22 Mar 2022).
    • 20 Apr 2022 This trial has been completed in Czechia and Spain (End Date: 22 Mar 2022), according to European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top